The Alb-R26Met can be considered as a predisposition model, as the slightly enhanced MET levels leave hepatocytes vulnerable to the emergence of molecular events that trigger preneoplastic lesions and progression towards HCC. The gene discussed is ALB; the disease is hepatocellular carcinoma.